Kristin M. Tolle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kristin M. Tolle has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Hsinchun Chen
5 shared publicationsAnthony J. G. Hey
External Research, Microsoft Research, Redmond, VA, USA
2 shared publicationsHsiao-Hui Chow
2 shared publications- Cynthia LeRouge
Department of Information Systems & Business Analytics, College of Business, Florida International University, Miami, FL, United States
1 shared publication Denise J. Roe
1 shared publication- Gondy Leroy
University of Arizona
1 shared publication
Latest Publications
- Top Cited Papers
- 1 November 2013
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 82 (11) , e251-e268
User profiles and personas in the design and development of consumer health technologies
- 1 November 2013
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 82 (11) , e251-e268
Top Cited PapersUser profiles and personas in the design and development of consumer health technologies
- Top Cited Papers
- 18 July 2011
- Published by Institute of Electrical and Electronics Engineers (IEEE) in Proceedings of the IEEE
- Vol. 99 (8) , 1334-1337
The Fourth Paradigm: Data-Intensive Scientific Discovery [Point of View]
We are now seeing governments and funding agencies looking at ways to increase the value and pace of scientific research through increased or open access to both data and publications. In this point of view article, we wish to look at another aspect of these twin revolutions, namely, how to enable developers, designers and researchers to build intuitive,multimodal, user-centric, scientific applications that can aid and enable scientific research.
- 18 July 2011
- Published by Institute of Electrical and Electronics Engineers (IEEE) in Proceedings of the IEEE
- Vol. 99 (8) , 1334-1337
Top Cited PapersThe Fourth Paradigm: Data-Intensive Scientific Discovery [Point of View]
We are now seeing governments and funding agencies looking at ways to increase the value and pace of scientific research through increased or open access to both data and publications. In this point of view article, we wish to look at another aspect of these twin revolutions, namely, how to enable developers, designers and researchers to build intuitive,multimodal, user-centric, scientific applications that can aid and enable scientific research.
- Open Access
- 23 May 2010
- Published by Wiley in Concurrency and Computation: Practice and Experience
- Vol. 22 (17) , 2297-2299
Special Issue: Concurrency and Computation: Practice and Experience from the Microsoft eScience Workshop
- 23 May 2010
- Published by Wiley in Concurrency and Computation: Practice and Experience
- Vol. 22 (17) , 2297-2299
Open AccessSpecial Issue: Concurrency and Computation: Practice and Experience from the Microsoft eScience Workshop
- 8 April 2008
- Published by Taylor & Francis in Women's Studies
- Vol. 37 (3) , 173-175
Women and Technology: Reversing the Trends of Attrition and Obtaining a Balance
- 8 April 2008
- Published by Taylor & Francis in Women's Studies
- Vol. 37 (3) , 173-175
Women and Technology: Reversing the Trends of Attrition and Obtaining a Balance
- 1 December 2000
- Published by Elsevier in Decision Support Systems
- Vol. 30 (2) , 139-151
Estimating drug/plasma concentration levels by applying neural networks to pharmacokinetic data sets
- 1 December 2000
- Published by Elsevier in Decision Support Systems
- Vol. 30 (2) , 139-151
Estimating drug/plasma concentration levels by applying neural networks to pharmacokinetic data sets
- 1 January 2000
- Published by Wiley in Journal of the American Society for Information Science
- Vol. 51 (4) , 352-370
Comparing noun phrasing techniques for use with medical digital library tools
- 1 January 2000
- Published by Wiley in Journal of the American Society for Information Science
- Vol. 51 (4) , 352-370
Comparing noun phrasing techniques for use with medical digital library tools
- 1 January 2000
- Published by Springer Nature
- p. 365-382
Intelligent Software Agents for Electronic Commerce
- 1 January 2000
- Published by Springer Nature
- p. 365-382
Intelligent Software Agents for Electronic Commerce
- 1 January 2000
- Published by Wiley in Journal of the American Society for Information Science
- Vol. 51 (4)
Comparing noun phrasing techniques for use with medical digital library tools
- 1 January 2000
- Published by Wiley in Journal of the American Society for Information Science
- Vol. 51 (4)
Comparing noun phrasing techniques for use with medical digital library tools
- 1 July 1997
- Published by American Geophysical Union (AGU) in Journal of Pharmaceutical Sciences
- Vol. 86 (7) , 840-845
Application of Neural Networks to Population Pharmacokinetic Data Analysis
This research examined the applicability of using a neural network approach to analyze population pharmacokinetic data. Such data were collected retrospectively from pediatric patients who had received tobramycin for the treatment of bacterial infection. The information collected included patient-related demographic variables (age, weight, gender, and other underlying illness), the individual's dosing regimens (dose and dosing interval), time of blood drawn, and the resulting tobramycin concentration. Neural networks were trained with this information to capture the relationships between the plasma tobramycin levels and the following factors: patient-related demographic factors, dosing regimens, and time of blood drawn. The data were also analyzed using a standard population pharmacokinetic modeling program, NON-MEM. The observed vs predicted concentration relationships obtained from the neural network approach were similar to those from NONMEM. The residuals of the predictions from neural network analyses showed a positive correlation with that from NONMEM. Average absolute errors were 33.9 and 37.3% for neural networks and 39.9% for NONMEM. Average prediction errors were found to be 2.59 and -5.01% for neural networks and 17.7% for NONMEM. We concluded that neural networks were capable of capturing the relationships between plasma drug levels and patient-related prognostic factors from routinely collected sparse within-patient pharmacokinetic data. Neural networks can therefore be considered to have potential to become a useful analytical tool for population pharmacokinetic data analysis.
- 1 July 1997
- Published by American Geophysical Union (AGU) in Journal of Pharmaceutical Sciences
- Vol. 86 (7) , 840-845
Application of Neural Networks to Population Pharmacokinetic Data Analysis
This research examined the applicability of using a neural network approach to analyze population pharmacokinetic data. Such data were collected retrospectively from pediatric patients who had received tobramycin for the treatment of bacterial infection. The information collected included patient-related demographic variables (age, weight, gender, and other underlying illness), the individual's dosing regimens (dose and dosing interval), time of blood drawn, and the resulting tobramycin concentration. Neural networks were trained with this information to capture the relationships between the plasma tobramycin levels and the following factors: patient-related demographic factors, dosing regimens, and time of blood drawn. The data were also analyzed using a standard population pharmacokinetic modeling program, NON-MEM. The observed vs predicted concentration relationships obtained from the neural network approach were similar to those from NONMEM. The residuals of the predictions from neural network analyses showed a positive correlation with that from NONMEM. Average absolute errors were 33.9 and 37.3% for neural networks and 39.9% for NONMEM. Average prediction errors were found to be 2.59 and -5.01% for neural networks and 17.7% for NONMEM. We concluded that neural networks were capable of capturing the relationships between plasma drug levels and patient-related prognostic factors from routinely collected sparse within-patient pharmacokinetic data. Neural networks can therefore be considered to have potential to become a useful analytical tool for population pharmacokinetic data analysis.